The AGM100® provides an objective measure of pulmonary gas exchange in COPD patients.
The AGM100® is a powerful clinical tool. Designed with clinicians in mind, it is lightweight, portable, and non-invasive. Coupled with an average two minute turnaround time for results, the AGM100® is ideal for assessing gas exchange inefficiency.
With the AGM100® there is no need to coach patients through complicated maneuvers.
The COPD Foundation recently published a study about the readmission rates of patients with COPD. “After discharge, 10% to 20% of COPD patients are readmitted within 30 days.10,11 Patients who are readmitted following a COPD hospitalization are at greater risk of mortality and have worse outcomes relative to patients who are not readmitted.12 A number of interventions have been proposed to reduce readmissions.13 However, these interventions have not shown a reduction in readmissions and mortality.13 One reason may be the inability to identify patients at the greatest risk of readmission and to target resources to these high-risk patients.”*
The MediPines Gas Exchange Monitor (AGM100®) is a non-invasive, multi-parameter respiratory monitoring device that provides spot-check respiratory gas measurements. The AGM100® is indicated for use in various clinical settings under clinicians’ judgement (professional healthcare facilities) when assessment of gas exchange status is required on conscious and cooperative adult patients. The AGM100® is not to be utilized simultaneously with supplemental oxygen nor with other respiratory gases or agents. It is not intended to be used as the sole basis for making diagnosis or treatment decisions related to patient gas exchange; it is intended to be used in conjunction with additional methods of assessing clinical signs and symptoms. It is not intended to replace arterial blood gas sampling for diagnosis or treatment purposes.
The lack of an objective measure of pulmonary gas exchange can lead to unnecessary hospital admissions that have the potential to result in across-the0board penalization of government payer reimbursement. Hospitals face up to a 3% loss of total Medicare reimbursement if their readmission rates are beyond the standards set for that year. The MediPines Gas Exchange Monitor® provides clinicians with an objective repeatable measure of gas exchange efficiency. The AGM100® is a tool that could drastically benefit the hospital in determining whether a patients’ Oxygen Deficit has reached an acceptable,* non-exacerbated level.
* Acceptable levels are determined by individual hospital clinical standards.